Media-OutReach Newswire The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
Media-OutReach Newswire Immuno Cure Biotech Presents Promising Results on Phase I Clinical Trial of a Therapeutic HIV DNA Vaccine
Media-OutReach Newswire PLDT Selects Amdocs to Digitally Transform its Network Operations for Greater Agility and Enhanced Customer Experience
Media-OutReach Newswire Allianz Commercial: Shipping losses hit all-time low despite increasing risks for the whole sector
Media-OutReach Newswire Poredeen Appoints ICB as Exclusive Named Patient Program Manager for HMTM# in Hong Kong and Macau
Media-OutReach Newswire Nanyang Inc. Spearheads Work Safety Initiative For The Outdoor Events Industry